會通股份(688219.SH):核心技術人員李榮羣和吳摞離職
格隆匯4月7日丨會通股份(688219.SH)公佈,因公司參股公司普立思生物科技有限公司(簡稱“普立思”)聚乳酸項目進度需要,公司副總經理、核心技術人員李榮羣於近日向公司申請辭去公司副總經理職務,李榮羣將擔任普立思總經理職務,負責普立思的日常經營工作。離職後,將不再擔任公司除董事以外的任何職務。
公司核心技術人員吳摞於近日因個人原因向公司申請辭去相關職務並辦理完成離職手續。離職後,吳摞不再擔任公司任何職務。
李榮羣和吳摞離職後,其負責的工作分別由公司副總經理、技術總監王燦耀和閆溥負責,李榮羣和吳摞的離職不會對公司的技術研發和生產經營帶來實質性影響,不會影響公司擁有的核心技術。
公司結合副總經理、技術總監王燦耀的任職履歷,以及對公司核心技術研發的領導和參與情況等相關因素,認定其為公司核心技術人員。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.